From the Editor - BioPharm International

ADVERTISEMENT

From the Editor

Biopharma Takes a Nervous Glance Over Its Shoulder

May 1, 2014

Changes are needed to maintain US biopharma innovation leadership.

Publishing Beyond the Printed Page

April 1, 2014

More media options open publishing opportunities for bioprocessing experts and authors.

Defining Quality Metrics is No Easy Task

February 1, 2014

ISPE and PDA take on the challenge of recommending quality metrics.

Drugs At What Cost?

January 1, 2014

Generics, market dynamics, and global demand are changing drug spending patterns.

Jobs Are Better in Biopharma, But There Is Room for Improvement

December 1, 2013

Higher wages and employment rates give biopharm professionals an edge over counterparts in other industries.

New Funding and Approval Pathways Prove Popular

November 1, 2013

The JOBS Act and FDASIA show early signs of accelerating drug development.

Filling a Drug Safety Gap

August 1, 2013

As the Supreme Court ruled on generic-drug liability, FDA outlined new rules for warning labels.

The Pains of Change

July 1, 2013

Pharma and biotech companies, with the rest of the healthcare industry, must face change.

Trust in the Pill Bottle

June 1, 2013

Ranbaxy's $500 million settlement for producing adulterated drugs and fradulent data provides a cautionary tale for patients, FDA, and drug manufacturers.

ADVERTISEMENT

ADVERTISEMENT

Click here